| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |